CCAAT/ENHANCER BINDING PROTEIN-Beta (C/EBPBeta IS A MOLECULAR TARGET FOR CANCER TREATMENT

Details for Australian Patent Application No. 2002340121 (hide)

Owner NORTH CAROLINA STATE UNIVERSITY

Inventors STERNECK, Esta, G.; JOHNSON, Peter, F.; SMART, Robert, C.; ZHU, Songyun

Pub. Number AU-A-2002340121

PCT Number PCT/US02/32018

PCT Pub. Number WO2003/030825

Priority 60/327,962 09.10.01 US

Filing date 4 October 2002

Wipo publication date 22 April 2003

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/327,962 09.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002340121

24 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002340122-PATHOLOGICAL TISSUE DETECTION AND TREATMENT EMPLOYING TARGETED BENZOINDOLE OPTICAL AGENTS

2002340120-SEMISOLID TOPICAL HORMONAL COMPOSITIONS AND METHODS FOR TREATMENT